Hacker News new | ask | show | jobs
by grk 2995 days ago
This sounds extremely weird when you read it in Europe.
4 comments

We in Europe have the same choices to face. For example,

" In June, Nice said the £48,000 per year price tag of the drug, which could benefit 450 women a year, could not be justified."

https://www.telegraph.co.uk/news/health/11785840/NICE-refuse...

Doesn't to me. Deploying limited resources effectively is critical to all care-giving. There is no "costs don't matter" in Europe.

The US aspect that is weird is when the discussion is not really about maximising value, its actually about maximising profits.

No it does not. There are treatments that are deemed to expensive and will not be provided. Typically it will be a trade off between how effective the treatment is and how expensive it is. European healtcare systems does not have infinite money.